Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-030143
Filing Date
2025-02-28
Accepted
2025-02-28 17:05:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3830
  Complete submission text file 0000950170-25-030143.txt   5375
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Subject) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38792 | Film No.: 25691955
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ALECTOR, INC 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Kenkare-Mitra Sara (Reporting) CIK: 0001895592 (see all company filings)

Type: 144